For the Inventor, By the Inventor

Enter inventor name

Catia Traversari

USPTO Granted Patents = 23 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 11

Forward Citations = 369(Granted Patents)

Company Filing History:

Ludwig Institute for Cancer Research Limited

Ludwig Institute

Glycostem Therapeutics B.v.

5. 1 out of 832,891

Other

patents

Years Active: 1994-2025

Loading Chart...

Loading Chart...

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12304962 - CAR NK cells (2025-05-20),

2. 7923534 - Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 (2011-04-12),

3. 7413733 - Antigen transduced T cells used as a delivery system for antigens (2008-08-19),

4. RE40089 - Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor (2008-02-18),

5. 6531451 - Tumor antigens and CTL clones isolated by a novel procedure (2003-03-11),

6. 6488932 - Method for treating cancer by administering MAGE-derived peptides (2002-12-03),

7. 6379901 - Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules (2002-04-30),

8. 6353089 - Method for stimulating CTLs with peptides (2002-03-05),

9. 6222012 - Isolated nonapeptides presented by HLA molecules, and uses thereof (2001-04-24),

10. 6201111 - Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors (2001-03-13),

11. 6034214 - Isolated nonapeptides which bind to HLA molecules and provoke lysis by (2000-03-07),

12. 6019987 - Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules (2000-02-01),

13. 6001975 - Precursor processed to at least one tumor rejection antigen presented by (1999-12-14),

14. 5925729 - Tumor rejection antigen precursors, tumor rejection antigens and uses (1999-07-20),

15. 5856091 - Isolated nucleic acid sequence coding for a tumor rejection antigen (1999-01-05),

Title: Catia Traversari - Innovative Inventor from Milan

Introduction: Catia Traversari is a pioneering inventor hailing from Milan, Italy, known for her groundbreaking contributions to various fields through her innovative patents.

Latest Patents: Catia Traversari's latest patents include advancements in renewable energy technologies, sustainable materials, and medical devices, showcasing her diverse range of expertise and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Catia Traversari has established herself as a prominent figure in the world of innovation, holding numerous patents that have significantly impacted industries worldwide.

Collaborations: Throughout her career, Catia Traversari has collaborated with leading research institutions, universities, and companies to bring her inventions to life, fostering a culture of innovation and collaboration in the process.

Conclusion: Catia Traversari's relentless pursuit of innovation and her passion for creating solutions to complex challenges have solidified her reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…